Dyssomnias  >>  ropinirole IR  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ropinirole IR / Generic mfg.
NCT00363857: A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome

Completed
3
360
US
Ropinirole
GlaxoSmithKline
Restless Legs Syndrome (RLS), Restless Legs Syndrome
05/04
05/04
NCT00225862: A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Completed
3
140
US
ropinirole
GlaxoSmithKline
Restless Legs Syndrome
 
12/05
NCT00197080: Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Completed
3
380
US, Canada
Ropinirole Extended Release (XR)
GlaxoSmithKline
Restless Legs Syndrome
 
01/06
NCT00314860: RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

Completed
3
568
US, Europe, RoW
ropinirole Extended Release (XR)
GlaxoSmithKline
Restless Legs Syndrome, Restless Legs Syndrome (RLS)
12/06
12/06
NCT00355641: Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

Completed
3
450
US, Canada
Ropinirole Extended Release (XR)
GlaxoSmithKline
Restless Legs Syndrome
10/07
10/07
NCT00357097: The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Completed
3
240
Europe
Ropinirole
GlaxoSmithKline
Restless Legs Syndrome, Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)
12/07
12/07
NCT00367822 / 2005-003549-16: Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Completed
3
300
Europe
Lisuride, Ropinirole, Placebo
Axxonis Pharma AG
Restless Legs Syndrome
 
 

Download Options